We are live on ! Find out more
DSCI

Derma Sciences, Inc. Common Stock (DE)
DSCI

Delisted

DSCI was delisted on the 23rd of February, 2017.

Back to rankings

59 hedge funds and large institutions have $95.3M invested in Derma Sciences, Inc. Common Stock (DE) in 2015 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 13

29% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 14

7% more funds holding

Funds holding: 55 → 59 (+4)

1% more capital invested

Capital invested by funds: $94.7M → $95.3M (+$594K)

49% less call options, than puts

Call options by funds: $64K | Put options by funds: $125K

Holders
59
Holders Change
+4
Holders Change %
+7.27%
% of All Funds
1.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
19
Reduced
13
Closed
14
Calls
$64K
Puts
$125K
Net Calls
-$61K
Net Calls Change
-$26K

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$12.4M
2
KAM
Krensavage Asset Management
New York
+$4.28M
3
RCM
RA Capital Management
Massachusetts
+$3.04M
4
GIM
Granahan Investment Management
Massachusetts
+$2.24M
5
BBA
Baker Bros. Advisors
New York
+$1.4M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$11.7M
2
DM
Deerfield Management
New York
-$4.72M
3
CCM
Consonance Capital Management
New York
-$4.53M
4
JGC
J. Goldman & Co
New York
-$2.1M
5
Millennium Management
Millennium Management
New York
-$1.89M

DSCI Hedge Fund Activity: Q4 2015 in Review

59 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Derma Sciences, Inc. Common Stock (DE) (DSCI) for Q4 2015, worth a combined $95.3M — up 0.63% from $94.7M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new DSCI positions and 14 closed out — a net gain of 4 holders — while 19 added to existing stakes and 13 trimmed.

The largest buyer was Franklin Resources, opening a new position worth an estimated $12.4M. The largest seller was Fidelity Investments, exiting entirely with an estimated $11.7M sold.

  • 59 institutional investors held Derma Sciences, Inc. Common Stock (DE) (DSCI) as of Q4 2015, up from 55 in Q3 2015.
  • Funds reported $95.3M of Derma Sciences, Inc. Common Stock (DE) stock for Q4 2015, up 0.63% quarter-over-quarter.
  • 18 funds opened new Derma Sciences, Inc. Common Stock (DE) positions in Q4 2015 and 14 closed out, a net change of +4 holders.
  • The largest Derma Sciences, Inc. Common Stock (DE) buyer in Q4 2015 was Franklin Resources, an estimated $12.4M added.
  • The largest Derma Sciences, Inc. Common Stock (DE) seller in Q4 2015 was Fidelity Investments, an estimated $11.7M sold.

Based on aggregated 13F filings for Q4 2015.